The Immune Tolerance Network (ITN) provides the standard operating procedures and protocols developed by ITN personnel and collaborators for use by the research community. Please note that no technical support is available. All works are licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 2.5 License.
The following are the standard operating procedures and protocols developed and used by the ITN/JDRF Type 1 Diabetes (T1D) Preclinical Consortium. The ITN/JDRF T1D Preclinical Consortium consists of four, independent, geographically diverse laboratories with the goal of generating reproducible data using a single protocol and standardized operating procedures. The consortium conducts pre-clinical screening for strategic combinations of agents to demonstrate safety and efficacy before moving into clinical trials.